Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Sham-Controlled, Double-Blind, Crossover Study to Evaluate PEMF Therapy on Pain Sensitivity to Different Qualities of Experimentally Induced Pain in Subjects With Painful Peripheral Diabetic Neuropathy

NCT02809911 is registered in ClinicalTrials.gov with Regenesis Biomedical, Inc. as lead sponsor.

NCT NCT02809911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Sham-Controlled, Double-Blind, Crossover Study to Evaluate PEMF Therapy on Pain Sensitivity to Different Qualities of Experimentally Induced Pain in Subjects With Painful Peripheral Diabetic Neuropathy
Lead sponsor
Regenesis Biomedical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2016
Completion date
August 31, 2016
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

painful peripheral diabetic neuropathy